Guidelines for Malaria Prevention in Travellers from the United Kingdom for 2003
Overview
Authors
Affiliations
This updated guidance from the Advisory Committee on Malaria Prevention for UK Travellers provides the essential information for healthcare workers who advise travellers. The many personal, visit and location-specific factors that need to be taken into account are discussed. Tables include the available antimalarials for prophylaxis and for standby treatment, appropriate choices of regimen by region and country for malarious areas, and the adjustments needed for children and in concomitant disease. There is greater emphasis on mefloquine, doxycycline and atovaquone/proguanil as the three options for highly chloroquine-resistant falciparum malarious areas, and changes in emergency standby medication.
Boggild A, Brophy J, Charlebois P, Crockett M, Geduld J, Ghesquiere W Can Commun Dis Rep. 2018; 40(7):118-132.
PMID: 29769893 PMC: 5864439. DOI: 10.14745/ccdr.v40i07a01.
Hill N, Lenglet A, Arnez A, Carneiro I BMJ. 2007; 335(7628):1023.
PMID: 17940319 PMC: 2078668. DOI: 10.1136/bmj.39356.574641.55.
Imported malaria to Northern Ireland: improving surveillance for better intervention.
Ong G, Smyth B Ulster Med J. 2006; 75(2):129-35.
PMID: 16755943 PMC: 1891728.
Chemoprophylaxis and malaria death rates.
Krause G, Schoneberg I, Altmann D, Stark K Emerg Infect Dis. 2006; 12(3):447-51.
PMID: 16704783 PMC: 3291437. DOI: 10.3201/eid1203.050736.
Malaria: diagnosis and treatment of falciparum malaria in travelers during and after travel.
Magill A Curr Infect Dis Rep. 2006; 8(1):35-42.
PMID: 16448599 DOI: 10.1007/s11908-006-0033-5.